<code id='91DA5D9C6E'></code><style id='91DA5D9C6E'></style>
    • <acronym id='91DA5D9C6E'></acronym>
      <center id='91DA5D9C6E'><center id='91DA5D9C6E'><tfoot id='91DA5D9C6E'></tfoot></center><abbr id='91DA5D9C6E'><dir id='91DA5D9C6E'><tfoot id='91DA5D9C6E'></tfoot><noframes id='91DA5D9C6E'>

    • <optgroup id='91DA5D9C6E'><strike id='91DA5D9C6E'><sup id='91DA5D9C6E'></sup></strike><code id='91DA5D9C6E'></code></optgroup>
        1. <b id='91DA5D9C6E'><label id='91DA5D9C6E'><select id='91DA5D9C6E'><dt id='91DA5D9C6E'><span id='91DA5D9C6E'></span></dt></select></label></b><u id='91DA5D9C6E'></u>
          <i id='91DA5D9C6E'><strike id='91DA5D9C6E'><tt id='91DA5D9C6E'><pre id='91DA5D9C6E'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:2581
          Richard Neal. -- health policy coverage from STAT
          Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

          WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

          Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

          advertisement

          “There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          FDA approves first treatment for ultra
          FDA approves first treatment for ultra

          AdobeU.S.regulatorsonWednesdayapprovedthefirsttreatmentforanultra-rarediseasethatcausespeopletogrowb

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          A new study sees potential in DNA sequencing of infants

          AdobeThere’sgrowingevidencethatDNAsequencingcanhelpdiagnosethehealthcaresystem’syoungestpatients—bab